Drug for Schizophrenia, Bipolar Disorder Gets FDA Approval
VRAYLAR (cariprazine), an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar disorder and for treatment of schizophrenia in adults.
Posted On Sep 18 2015